Accueil
Détail de l'auteur
Auteur G. F. X. FEENEY |
Documents disponibles écrits par cet auteur (4)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
In May 2002 Buprenorphine (Subutex) was listed on the Australian Pharmaceutical Benefits Schedule for treatment in opioid dependence. In addition to broadening treatment options, buprenorphine has the advantage of an improved safety profile. The[...]Périodique
G. F. X. FEENEY ; J. P. CONNOR ; R. M. D. YOUNG ; J. TUCKER ; MAC PHERSON A. | 2006ENGLISH : This trial of cognitivebehavioural therapy (CBT) based amphetamine abstinence program (n = 507) focused on refusal self-efficacy, improved coping, improved problem solving and planning for relapse prevention. Measures included the Se[...]Article : Périodique
D. J. STATHAM ; J. P. CONNOR ; D. J. KAVANAGH ; G. F. X. FEENEY ; R. M. YOUNG ; J. MAY ; J. ANDRADE |AIMS. To develop a measure of craving based on the Elaborated Intrusion (EI) theory of desire and to examine the construct, concurrent and discriminant validity of the instrument. DESIGN. Cross-sectional. SETTING AND PARTICIPANTS. Patients from [...]Article : Périodique
Background: Outcome expectancies are a key cognitive construct in the etiology, assessment and treatment of Substance Use Disorders. There is a research and clinical need for a cannabis expectancy measure validated in a clinical sample of cannab[...]